SAN DIEGO--(BUSINESS WIRE)-- Janux Therapeutics, Inc. (Nasdaq: JANX ... today announced that it has commenced an underwritten public offering of $300.0 million of shares of its common stock ...

Protara Therapeutics (TARA) announced that it has commenced an underwritten public offering of shares of its common stock or, in lieu of issuing common stock to certain investors, pre-funded ...

Equities research analysts at Cantor Fitzgerald increased their FY2024 earnings estimates for PTC Therapeutics in a report ...

(RTTNews) - BriaCell Therapeutics Corp. (BCTX), a clinical-stage biotechnology company, Thursday announced the pricing of an underwritten public offering ... at $1.10 on the Nasdaq.

Dermata Therapeutics (NASDAQ:DRMA) is raising ~$2.55M in a private offering priced at-the-market under Nasdaq rules. The company is offering 2,007,880 shares of its common stock (or pre-funded ...

WARREN, N.J. - PTC Therapeutics (NASDAQ:PTCT) disclosed Thursday that its PTC518 program for Huntington's disease has been granted Fast Track designation by the FDA, a status... PTC Therapeutics ...

--(BUSINESS WIRE)-- Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced that it has commenced an underwritten public offering of shares of its common stoc ...

Hoth Therapeutics (HOTH ... The company affirms that it has no plans for a public or private offering at this time. Hoth’s financial position remains robust, with a strong balance sheet that ...

WARREN, N.J., Dec. 17, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Dec. 13, 2024, the company approved non-statutory stock options to purchase an aggregate ...

Cayman Islands, January 15, 2025 -- Silexion Therapeutics Corp (NASDAQ: SLXN ... today announced the pricing of a public offering of an aggregate of 3,703,703 of the Company’s ordinary ...